737
Views
126
CrossRef citations to date
0
Altmetric
Review

A review of small molecules and drug delivery applications using gold and iron nanoparticles

, , , , &
Pages 1633-1657 | Published online: 11 Mar 2019

Figures & data

Table 1 Overview of Au-NPs/5-FU and their applications

Figure 1 Targeted delivery of 5-FU to cholangiocarcinoma cells using folic acid. Note: Data from Ngernyuang et al.Citation27

Abbreviation: 5-FU, 5-fluorouracil.

Figure 1 Targeted delivery of 5-FU to cholangiocarcinoma cells using folic acid. Note: Data from Ngernyuang et al.Citation27Abbreviation: 5-FU, 5-fluorouracil.

Table 2 Overview of Au-NPs/FA and their applications

Figure 2 Bioconjugation of gold nanobipyramids for the detection of SERS and targeted photothermal therapy in breast cancer.

Note: Data from Feng et al.Citation40

Abbreviations: SERS, surface-enhanced raman scattering; PTT, photothermal therapy; EM, electromagnetic field.

Figure 2 Bioconjugation of gold nanobipyramids for the detection of SERS and targeted photothermal therapy in breast cancer.Note: Data from Feng et al.Citation40Abbreviations: SERS, surface-enhanced raman scattering; PTT, photothermal therapy; EM, electromagnetic field.

Table 3 Overview of Au-NPs/DOX, Au-NPs/paclitaxel (PTX), and their applications

Figure 3 Protein-gold cluster-capped mesoporous silica NPs for high drug loading, autonomous gemcitabine/DOX codelivery, and in vivo tumor imaging.

Note: Data from Croissant et al.Citation58

Abbreviations: Au-NCs, gold nanoclusters; DOX, doxorubicin; MSN, mesoporous silica nanoparticle; NPs, nanoparticles.

Figure 3 Protein-gold cluster-capped mesoporous silica NPs for high drug loading, autonomous gemcitabine/DOX codelivery, and in vivo tumor imaging.Note: Data from Croissant et al.Citation58Abbreviations: Au-NCs, gold nanoclusters; DOX, doxorubicin; MSN, mesoporous silica nanoparticle; NPs, nanoparticles.

Figure 4 PTX-loaded chitosan oligosaccharide-stabilized Au-NPs as novel agents for drug delivery and photoacoustic imaging of cancer cells.

Note: Data from Manivasagan et al.Citation78

Abbreviations: Au-NPs, gold nanoparticles; COS, chitosan oligosaccharide; PTX, paclitaxel.

Figure 4 PTX-loaded chitosan oligosaccharide-stabilized Au-NPs as novel agents for drug delivery and photoacoustic imaging of cancer cells.Note: Data from Manivasagan et al.Citation78Abbreviations: Au-NPs, gold nanoparticles; COS, chitosan oligosaccharide; PTX, paclitaxel.

Figure 5 Overall scheme for the biosynthesis of Au-NPs using COS, subsequent loading of PTX on COS-stabilized Au-NPs (COS Au-NPs), and the possible mechanism for the cellular uptake of loaded COS-stabilized Au-NPs (PTX-COS Au-NPs) in MDA-MB-231 cancer cells.

Note: Data from Manivasagan et al.Citation78

Abbreviations: Au-NPs, gold nanoparticles; COS, chitosan oligosaccharide; PTX, paclitaxel.

Figure 5 Overall scheme for the biosynthesis of Au-NPs using COS, subsequent loading of PTX on COS-stabilized Au-NPs (COS Au-NPs), and the possible mechanism for the cellular uptake of loaded COS-stabilized Au-NPs (PTX-COS Au-NPs) in MDA-MB-231 cancer cells.Note: Data from Manivasagan et al.Citation78Abbreviations: Au-NPs, gold nanoparticles; COS, chitosan oligosaccharide; PTX, paclitaxel.

Table 4 Overview of iron oxide nanoparticles/drugs and their applications

Figure 6 Controlled release of 5-fluorouracil from CS-PEG/PGS-PEG-coated iron oxide.

Note: Data from Naghizadeh et al.Citation105

Abbreviations: CS-PEG, chitosan-co-poly(ethylene glycol); PGS-PEG, poly(glycerol sebacate)-co-poly(ethylene glycol).

Figure 6 Controlled release of 5-fluorouracil from CS-PEG/PGS-PEG-coated iron oxide.Note: Data from Naghizadeh et al.Citation105Abbreviations: CS-PEG, chitosan-co-poly(ethylene glycol); PGS-PEG, poly(glycerol sebacate)-co-poly(ethylene glycol).

Figure 7 Smart multifunctional magnetic nanoparticle-based drug delivery system for cancer thermo-chemotherapy and intracellular imaging.

Note: Data from Shen et al.Citation109

Abbreviations: CHI, chitosan; PNIPAM, poly(N-isopropylacrylamide); TEOS, tetraethyl orthosilicate.

Figure 7 Smart multifunctional magnetic nanoparticle-based drug delivery system for cancer thermo-chemotherapy and intracellular imaging.Note: Data from Shen et al.Citation109Abbreviations: CHI, chitosan; PNIPAM, poly(N-isopropylacrylamide); TEOS, tetraethyl orthosilicate.

Figure 8 pH-sensitive biocompatible mesoporous magnetic nanoparticles labeled with folic acid as an efficient carrier for controlled anticancer drug delivery.

Note: Data from Avedian et al.Citation114

Abbreviations: MSN, mesoporous silica nanoparticle; PEI, polyethylenimine.

Figure 8 pH-sensitive biocompatible mesoporous magnetic nanoparticles labeled with folic acid as an efficient carrier for controlled anticancer drug delivery.Note: Data from Avedian et al.Citation114Abbreviations: MSN, mesoporous silica nanoparticle; PEI, polyethylenimine.

Figure 9 Novel folic acid-conjugated Fe3O4-ZnO hybrid nanoparticles for targeted photodynamic therapy.

Note: Data from Kim et al.Citation123

Figure 9 Novel folic acid-conjugated Fe3O4-ZnO hybrid nanoparticles for targeted photodynamic therapy.Note: Data from Kim et al.Citation123

Figure 10 DOX-loaded Fe3O4@MoS2-PEG-2DG nanocubes as a theranostic platform for MRI-guided chemo-photothermal therapy of breast cancer.

Note: Data from Xie et al.Citation137

Abbreviations: DOX, doxorubicin; IO, iron oxide; IOMS, Fe3O4@molybdenum sulfide; NCs, nanoclusters; PEG, polyethylene glycol; PTT, photothermal therapy.

Figure 10 DOX-loaded Fe3O4@MoS2-PEG-2DG nanocubes as a theranostic platform for MRI-guided chemo-photothermal therapy of breast cancer.Note: Data from Xie et al.Citation137Abbreviations: DOX, doxorubicin; IO, iron oxide; IOMS, Fe3O4@molybdenum sulfide; NCs, nanoclusters; PEG, polyethylene glycol; PTT, photothermal therapy.

Figure 11 Sacrificial template-directed fabrication of superparamagnetic polymer microcontainers for the pH-activated controlled release of Dau.

Note: Data from Chatzipavlidis et al.Citation168

Abbreviations: MNPs, magnetic nanoparticles; PMAA, poly(methacrylic acid); P(MBAAm-co-MAA), poly(N,N0-methylenebis(acrylamide)-comathacrylic acid).

Figure 11 Sacrificial template-directed fabrication of superparamagnetic polymer microcontainers for the pH-activated controlled release of Dau.Note: Data from Chatzipavlidis et al.Citation168Abbreviations: MNPs, magnetic nanoparticles; PMAA, poly(methacrylic acid); P(MBAAm-co-MAA), poly(N,N0-methylenebis(acrylamide)-comathacrylic acid).